PEPTONIC MEDICAL (28L) — Cash Flow-to-Debt Ratio
Latest as of September 2025:
-0.25x
PEPTONIC MEDICAL (28L) has a Cash Flow-to-Debt Ratio of -0.25x as of September 2025, meaning its operating cash flow of €-7.43 Million could theoretically repay 0% of its total liabilities (€29.18 Million) in one year. Explore PEPTONIC MEDICAL (28L) cash flow conversion to assess how effectively this company generates cash.
CF-to-Debt Ratio
-0.25x
Operating CF / Total Liabilities
Operating Cash Flow
€-7.43 Million
EUR
Total Liabilities
€29.18 Million
EUR
Data as of
Sep 2025
Most recent filing
PEPTONIC MEDICAL Cash Flow-to-Debt Ratio (2021–2024)
Historical debt coverage capacity for PEPTONIC MEDICAL across 4 annual periods. Also explore PEPTONIC MEDICAL asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for PEPTONIC MEDICAL (2021–2024)
Year-by-year debt coverage analysis for PEPTONIC MEDICAL. For market capitalisation and broader financial context, see 28L market cap.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.71x | €-37.55 Million | €22.01 Million | ▼ -58.5% |
| 2023 | -1.08x | €-33.81 Million | €31.41 Million | ▼ -3.5% |
| 2022 | -1.04x | €-40.22 Million | €38.66 Million | ▲ +18.8% |
| 2021 | -1.28x | €-40.34 Million | €31.48 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.